| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Sagimet Biosciences Inc.
13G/A
Amendment 1
SGMT · 786700104
|
4.9% |
6/24/2025
Event 6/24/2025
|
|||
| AP11 Limited | 4.9% | ||||
| Ascletis Pharma Inc. | 4.9% | ||||
|
Sagimet Biosciences Inc.
13G
SGMT · 786700104
|
5.4% |
5/20/2025
Event 12/31/2023
|
|||
| AP11 Limited | 5.4% | ||||
| Ascletis Pharma Inc. | 5.4% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.